Michael Graupe,John O. Link,Chandrasekar Venkataramani
申请号：
US12605271
公开号：
US08518874B2
申请日:
2009.10.23
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
